Christopher Cavanaugh
Overview
Explore the profile of Christopher Cavanaugh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
899
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Alam M, Costales M, Cavanaugh C, Pereira M, Gaines D, Williams K
Microb Pathog
. 2016 Aug;
99:236-246.
PMID: 27574777
Foodborne Listeria monocytogenes (LM) is a cause of serious illness and death in the US. The case-fatality rate of invasive LM infection in the elderly population is >50%. The goal...
12.
Borges G, Vencio E, Quek S, Chen A, Salvanha D, Vencio R, et al.
J Cell Physiol
. 2016 Jan;
231(9):2040-7.
PMID: 26773436
The lineage relationship between prostate adenocarcinoma and small cell carcinoma was studied by using the LuCaP family of xenografts established from primary neoplasm to metastasis. Expression of four stem cell...
13.
La Torre A, Hoshino A, Cavanaugh C, Ware C, Reh T
Stem Cells
. 2015 May;
33(9):2674-85.
PMID: 26013465
During early patterning of the neural plate, a single region of the embryonic forebrain, the eye field, becomes competent for eye development. The hallmark of eye field specification is the...
14.
Alam M, Costales M, Cavanaugh C, Williams K
Biomolecules
. 2015 May;
5(2):775-92.
PMID: 25950510
Adenosine, an immunomodulatory biomolecule, is produced by the ecto-enzymes CD39 (nucleoside triphosphate dephosphorylase) and CD73 (ecto-5'-nucleotidase) by dephosphorylation of extracellular ATP. CD73 is expressed by many cell types during injury,...
15.
Ma W, Ay F, Lee C, Gulsoy G, Deng X, Cook S, et al.
Nat Methods
. 2014 Dec;
12(1):71-8.
PMID: 25437436
High-throughput methods based on chromosome conformation capture have greatly advanced our understanding of the three-dimensional (3D) organization of genomes but are limited in resolution by their reliance on restriction enzymes....
16.
Ware C, Nelson A, Mecham B, Hesson J, Zhou W, Jonlin E, et al.
Proc Natl Acad Sci U S A
. 2014 Mar;
111(12):4484-9.
PMID: 24623855
The naïve pluripotent state has been shown in mice to lead to broad and more robust developmental potential relative to primed mouse epiblast cells. The human naïve ES cell state...
17.
Zhou W, Choi M, Margineantu D, Margaretha L, Hesson J, Cavanaugh C, et al.
EMBO J
. 2012 Mar;
31(9):2103-16.
PMID: 22446391
The function of metabolic state in stemness is poorly understood. Mouse embryonic stem cells (ESC) and epiblast stem cells (EpiSC) are at distinct pluripotent states representing the inner cell mass...
18.
Vencio E, Nelson A, Cavanaugh C, Ware C, Milller D, Garcia J, et al.
Prostate
. 2012 Feb;
72(13):1453-63.
PMID: 22314551
Background: CD90(+) prostate cancer-associated (CP) stromal cells represent a diseased cell type found only in tumor tissue. They differ from their normal counterpart in gene expression and inductive signaling. Genetic...
19.
Bhamra R, Bolcsak L, Ahmad I, Schupsky J, Roberts P, Stevens R, et al.
Anticancer Drugs
. 2003 Jul;
14(6):481-6.
PMID: 12853892
TLC ELL-12 is a liposomal formulation of the novel antineoplastic compound 1-O-octadecyl-2-O-methyl-sn-glycero-3-phosphocholine (L-ET-18-OCH(3)). The purpose of these studies was to evaluate the activity and tissue distribution of L-ET-18-OCH(3) when administered...
20.
Bhamra R, Bolcsak L, Roberts P, Stevens R, Cavanaugh C, Swenson C
Anticancer Drugs
. 2003 Mar;
14(3):183-91.
PMID: 12634612
TLC ELL-12 is a liposomal formulation of the antineoplastic L-O-octadecyl-2-O-methyl-sn-glycero-3-phosphocholine [L-ET-18-OCH3 (EL)]. The purpose of these studies was to characterize the toxicity and disposition of [N-methyl-14C] L-ET-18-OCH3 administered as TLC...